JANUS HENDERSON INVESTORS US LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 102 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2014. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANUS HENDERSON INVESTORS US LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q2 2014$1,451,000
-50.9%
32,330
-46.5%
0.00%
-66.7%
Q1 2014$2,956,00060,4650.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2014
NameSharesValueWeighting ↓
Iguana Healthcare Management, LLC 140,000$6,847,0002.78%
WEATHERBIE CAPITAL, LLC 337,788$16,521,0002.34%
Opaleye Management Inc. 65,000$3,179,0002.12%
SPHERA FUNDS MANAGEMENT LTD. 105,000$5,136,0001.33%
Cormorant Asset Management, LP 110,842$5,421,0000.77%
Rock Springs Capital Management LP 141,500$6,921,0000.51%
COLUMBIA WANGER ASSET MANAGEMENT LLC 863,392$42,229,0000.49%
ROCKEFELLER FINANCIAL SERVICES INC 396,346$19,385,0000.39%
Opus Point Partners Management, LLC 7,074$346,0000.33%
Eventide Asset Management 87,400$4,275,0000.26%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders